Feb 21
|
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
|
Feb 21
|
PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise
|
Feb 21
|
Insulet Corp (PODD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion ...
|
Feb 20
|
Compared to Estimates, Insulet (PODD) Q4 Earnings: A Look at Key Metrics
|
Feb 20
|
Insulet (PODD) Q4 Earnings and Revenues Top Estimates
|
Feb 20
|
Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance Slightly Exceeds Expectations
|
Feb 20
|
Insulet: Q4 Earnings Snapshot
|
Feb 20
|
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-Year
|
Feb 20
|
Insulet Corporation's (NASDAQ:PODD) Intrinsic Value Is Potentially 25% Below Its Share Price
|
Feb 19
|
Insulet Earnings: What To Look For From PODD
|
Feb 14
|
Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key Metrics
|
Feb 6
|
If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity
|
Feb 3
|
Zacks.com featured highlights NVIDIA, AppLovin and Insulet
|
Jan 31
|
NVIDIA & 2 Other Profitable Stocks to Buy in February
|
Jan 10
|
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
|
Jan 7
|
Insulin Device Maker Has Analysts Turning Bullish
|
Jan 7
|
What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?
|
Dec 31
|
GEHC vs. PODD: Which Stock Is the Better Value Option?
|
Dec 31
|
Insulet price target raised to $300 from $270 at BTIG
|
Dec 19
|
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
|